Second Annual $500,000 XSeed Award Launched by Deerfield Management to Support Underfunded and Underrepresented NYC Life Science Startups

Milestone-based financing can be an effective way for investors to manage risk and for founders to complete successful clinical trials and gain regulatory approval. Here's what biotech entrepreneurs need to know before seeking this type of funding. 

The Pros and Cons of Milestone-Based Financing for Biotech Startups

Powered by innovative digital health technologies, decentralized clinical trials make leading-edge clinical research accessible to more people in their homes and communities.

How Decentralized Clinical Trials Are Reshaping Biotech Strategy

Whether pitching to angels, applying to accelerators, or negotiating venture capital, knowing the right funding terms can make or break your credibility as a healthcare founder. This guide breaks down the must-know concepts to help you speak the language of investors and secure the capital you need to grow.

The Language of Startup Funding: 35 Terms Every Founder Should Know 

The agency's decision to ease evidence requirements for a psoriasis drug application could lower costs and expand access to copycat biologic medicines.

FDA's Latest Move Could Pave the Way for Cheaper Complex Medicines

345 Park Avenue South

Cure by Deerfield Launches Middle East Health Accelerator in Qatar Image

Blue

News & Insights

Your Home in NYC

Cure Founders Pass Membership Benefits 03 Tab Bar Image

8 Early-Stage Hurdles Your Healthcare Startup Could Face—and How To Overcome Them

Cure by Deerfield Launches Middle East Health Accelerator in Qatar

Your Home in NYC

November 11 -13 , 2025

Cure Presents: The X Factor Healthcare Innovation Summit

Accelerating Advances in Health

Second Annual $500,000 XSeed Award Launched by Deerfield Management to Support Underfunded and Underrepresented NYC Life Science Startups

More Stories